Suppr超能文献

静脉注射昂丹司琼致致命性过敏反应:一例病例报告。

Fatal anaphylaxis to intravenous ondansetron: A case report.

作者信息

Sapkota Kalyan, Bhagat Roshan

机构信息

Department of Medicine Bharatpur Hospital Chitwan Nepal.

ICU Department of Medicine Bharatpur Hospital Chitwan Nepal.

出版信息

Clin Case Rep. 2021 May 5;9(5):e04110. doi: 10.1002/ccr3.4110. eCollection 2021 May.

Abstract

The safety and efficacy of ondansetron has led to its wider clinical use and this could increase unusual serious adverse events. Therefore, we emphasize the need for cautious use of ondansetron and beware and prepare for unusual adverse events.

摘要

昂丹司琼的安全性和有效性使其在临床上得到更广泛的应用,而这可能会增加罕见的严重不良事件。因此,我们强调需要谨慎使用昂丹司琼,并对罕见不良事件保持警惕并做好准备。

相似文献

1
Fatal anaphylaxis to intravenous ondansetron: A case report.
Clin Case Rep. 2021 May 5;9(5):e04110. doi: 10.1002/ccr3.4110. eCollection 2021 May.
2
Hypersensitivity to intravenous ondansetron: a case report.
J Med Case Rep. 2008 Aug 14;2:274. doi: 10.1186/1752-1947-2-274.
4
Anaphylactoid reactions associated with ondansetron.
Ann Pharmacother. 1994 Sep;28(9):1029-30. doi: 10.1177/106002809402800906.
5
7
Ondansetron anaphylaxis: a case report and protocol for skin testing.
Br J Anaesth. 2009 Feb;102(2):285-6. doi: 10.1093/bja/aen376.
8
Coronary vasospasm and atrial fibrillation associated with ondansetron therapy.
Ann Pharmacother. 2009 Mar;43(3):532-6. doi: 10.1345/aph.1L544. Epub 2009 Mar 3.
9
Ondansetron-Induced Anaphylactic Shock: An In-Depth Analysis of a Rare Adverse Event.
Cureus. 2023 Aug 3;15(8):e42894. doi: 10.7759/cureus.42894. eCollection 2023 Aug.

引用本文的文献

1
Ondansetron-Induced Anaphylactic Shock: An In-Depth Analysis of a Rare Adverse Event.
Cureus. 2023 Aug 3;15(8):e42894. doi: 10.7759/cureus.42894. eCollection 2023 Aug.
2
Ondansetron-induced pseudoallergy with non-ischemic myocardial injury: A rare case report of Kounis syndrome.
Clin Case Rep. 2022 Dec 22;10(12):e6781. doi: 10.1002/ccr3.6781. eCollection 2022 Dec.
3
Anaphylaxis induced by intra-articular injection of chitosan: A case report and literature review.
Clin Case Rep. 2022 Dec 9;10(12):e6596. doi: 10.1002/ccr3.6596. eCollection 2022 Dec.

本文引用的文献

1
Epinephrine: the drug of choice for anaphylaxis-a statement of the world allergy organization.
World Allergy Organ J. 2008 Jul;1(7 Suppl):S18-26. doi: 10.1097/WOX.0b013e31817c9338.
2
Ondansetron anaphylaxis: a case report and protocol for skin testing.
Br J Anaesth. 2009 Feb;102(2):285-6. doi: 10.1093/bja/aen376.
3
Hypersensitivity to intravenous ondansetron: a case report.
J Med Case Rep. 2008 Aug 14;2:274. doi: 10.1186/1752-1947-2-274.
4
Symposium on the definition and management of anaphylaxis: summary report.
J Allergy Clin Immunol. 2005 Mar;115(3):584-91. doi: 10.1016/j.jaci.2005.01.009.
5
Anaphylactic reaction to ondansetron.
Arch Intern Med. 2001 Oct 8;161(18):2263. doi: 10.1001/archinte.161.18.2263.
6
Anaphylactoid reactions associated with ondansetron.
Ann Pharmacother. 1994 Sep;28(9):1029-30. doi: 10.1177/106002809402800906.
7
A method for estimating the probability of adverse drug reactions.
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验